Cancer and Neurological Disease Diagnostic
With the advent of modern medicine and its contribution to the dramatic increase in human lifespan, cancer and neurological diseases have become one of the leading causes of mortality and morbidity globally. Diagnosing these diseases earlier can grant the patient a chance to increase one’s health and life span with better controlled symptoms, while allowing for families to prepare for the difficulties ahead. Therefore, detecting both cancer and neurological disorders early has become both a challenge and an objective for the medical community.
In order to address this problem, a team of Stanford University physicians, UC Berkeley PhD’s, and the 2013 Nobel Laureate chemist, gathered together to develop a sensitive and specific breath diagnostic for cancer and neurological diseases. This diagnostic aims to collect Volatile Organic Compounds(VOCs), which are compounds with high vapor pressure or volatility at room temperature, carried from the body to the lungs as products of endogenous biochemical processes. The breath diagnostic system is designed to detect signature patterns in VOC’s collected from patients to ascertain the presence of a multitude of cancers and neurodegenerative diseases, based on the clinical evidence that distinctive breath signatures could be indicative of various clinical conditions such as diabetes, liver failure, chronic renal disease, and certain inborn errors of metabolism such as cancer and neurological diseases.
Using a noninvasive and easy-to-collect sampling device, this diagnostic will first target colon cancer, prostate cancer, and multiple sclerosis on ABC’s Treatment Access Platform. These efforts will be closely followed by breast cancer, ovarian cancer, Alzheimer’s, and Parkinson’s.
In consideration that this breath diagnostic may detect stage 0 illnesses with or without standard treatment protocols, ABC is actively looking to expand its product platform to include novel cancer vaccines, immunotherapy and stem cell therapies as both therapeutic and preventative treatments.
*Note: For complete description of therapeutics and diagnostics with citations, please refer to ABC ICO Prospectus